Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia

Sutedja, T G; Apperley, J F; Hughes, J M; Aber, V R; Kennedy, H G; Nunn, P; Jones, L; Hopper, L; Goldman, J M
March 1988
Thorax;Mar1988, Vol. 43 Issue 3, p163
Academic Journal
No abstract available.


Related Articles

  • Immunosuppressants.  // Reactions Weekly;12/6/2008, Issue 1231, p17 

    The article describes the case of a woman, who had undergone bone marrow transplantation for chronic myeloid leukaemia (CML), who developed donor-derived acute myeloid leukaemia (AML) after receiving ciclosporin, prednisolone, azathioprine and mycophenolate mofetil. Azathioprine was discontinued...

  • Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation. Yong, A S M; Goldman, J M // Bone Marrow Transplantation;4/15/99, Vol. 23 Issue 8, p827 

    Allogeneic bone marrow transplantation (BMT) is the treatment of choice for patients with chronic myeloid leukaemia (CML) who are relatively young and have suitable donors. Relapse is rare more than 5 years after allografting. We describe a patient who relapsed with myeloid blast transformation...

  • Morphologic changes leading to bronchiolitis obliterans in a patient with delayed non-infectious lung disease after allogeneic bone marrow transplantation. Trisolini, R; Bandini, G; Stanzani, M; Chilosi, M; Cancellieri, A; Boaron, M; Poletti, V // Bone Marrow Transplantation;12/15/2001, Vol. 28 Issue 12, p1167 

    A 37-year-old man developed delayed non-infectious lung disease after undergoing bone marrow transplantation (BMT) for acute myeloid leukaemia. Over a 15-month period, the progression of morphologic changes from cellular interstitial pneumonia to bronchiolitis obliterans organizing pneumonia and...

  • Ciclosporin.  // Reactions Weekly;10/8/2011, Issue 1372, p13 

    The article describes the case of a man with acute myeloid leukaemia who underwent bone marrow transplantation and developed thrombotic thrombocytopenic purpura during treatment with ciclosporin.

  • Ciclosporin.  // Reactions Weekly;9/17/2011, Issue 1369, p14 

    The article describes the case of a woman who is a bone marrow transplant recipient with acute myeloid leukaemia who developed acute pancreatitis while being treated with ciclosporin.

  • Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplatation for chronic myelogenous leukemia. del Rosario Uriarte, M; Bonomi, R; Azambuja, C; Seuánez, H N // Leukemia (08876924);Dec97, Vol. 11 Issue 12, p2213 

    Discusses that la stem cell transplantation is the only procedure for a successful cure of chronic myeloid leukemia (CML). Significance of bone marrow transplantation in CML; Molecular biology of CML; Importance of monitoring the relapse after allogeneic bone marrow transplantation.

  • Imatinib.  // Reactions Weekly;12/8/2012, Issue 1431, p23 

    The article describes the case of a 46-year-old man who experienced bone marrow aplasia following treatment with imatinib for chronic myeloid leukaemia (CML).

  • Imatinib.  // Reactions Weekly;2/16/2008, Issue 1189, p21 

    The article describes the case of a 41-year-old man who developed bone marrow aplasia while receiving imatinib for chronic myeloid leukaemia. Over the first 3-4 months, the man's platelet count progressively decreased and on day 100 of treatment, grade 3 thrombocytopenia was recorded. About two...

  • Linezolid.  // Reactions Weekly;7/2/2005, Issue 1058, p13 

    Discusses research being done on the adverse effects of linezolid as a treatment for infections. Reference to a study by L. Palenzuela et al published in the June 2005 issue of "Clinical Infectious Diseases"; Symptoms experienced by a bone marrow transplant recipient with acute myeloid...

  • Late molecular relapse in two CML patients in molecular remission after donor lymphocyte transfusion for post-BMT relapse. Moravcová, J; Muchová, S; Lukášová, M; Klamová, H; Březinová, J; Gašová, Z // Bone Marrow Transplantation;4/15/99, Vol. 23 Issue 8, p857 

    Comments on an article dealing with donor lymphocyte transfusion (DLT) for treatment of chronic myeloid leukemia (CML) relapse in patients after bone marrow transplantation. Use of DLT in treating patients with CML relapse; Detection of cytogenetic relapse.


Read the Article


Sign out of this library

Other Topics